OmniWave Technologies

OmniWave Technologies is a medical device and biotechnology company focused on developing advanced ultrasound-based solutions for the treatment of vascular diseases. The company's core technology utilizes transverse ultrasonic waves to effectively break down blood clots (thrombolysis) without the need for high doses of thrombolytic drugs, potentially reducing bleeding risks. Their platform is designed to address critical conditions such as ischemic stroke, deep vein thrombosis, and peripheral arterial disease. By combining mechanical disruption with targeted energy delivery, OmniWave aims to provide faster and safer revascularization for patients with acute vascular blockages.